Evidence map›Paper›PMID 37834328›Full record

ArticleInternational journal of molecular sciences2023

Effect of Cannabidiol on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells.

Alessia Furgiuele, Franca Marino, Emanuela Rasini, Massimiliano Legnaro, Alessandra Luini, Maria Giulia Albizzati, Alessia di Flora, Barbara Pacchetti, Marco Cosentino

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Alessia FurgiueleCenter for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.
Franca MarinoCenter for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.ORCID 0000-0003-1837-7810
Emanuela RasiniCenter for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.ORCID 0009-0001-1334-3817
Massimiliano LegnaroCenter for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.
Alessandra LuiniCenter for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.
Maria Giulia AlbizzatiCenter for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.
Alessia di FloraCenter for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.
Barbara PacchettiCenter for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.
Marco CosentinoCenter for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.ORCID 0000-0002-6978-7775
University of Insubria · IT

Funding

Emmac Switzerland (now Curaleaf International) 03/07/2019.
6 · The paper itself

Abstract

Cannabidiol (CBD), the main non-psychoactive component of

Indexed as

CannabidiolCD4-Positive T-LymphocytesCytokinesHumansLeukocytes, MononuclearRNA, MessengerCannabidiolCytokinesRNA, Messengercannabidiolcell differentiationcell proliferationIFN-γTNF-α

Identifiers

PMID37834328
PMCPMC10573927
OpenAlexW4387334540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.